Modest correlation between IVUS and FFR in intermediate lesions assessment

Original title: FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study Reference: Ron Waksman et al. J Am Coll Cardiol 2013. Article in Press

For patients with angiographically assessed intermediate lesions such as stenosis between 40% and 80%, criteria that favor revascularization remains under debate. 

Fractional Flow Reserve (FFR) is considered the gold standard to assess intermediate lesions, and ≤ 0.8 is considered a significative value. Intravascular ultrasound has traditionally used a 4 mm2 cut-off minimum lumen area (MLA) to classify a lesion as severe; however, this cut-off IVUS value has not been proved equivalent to the functional parameter of FFR.

This prospective, multicenter registry designed to determine the correlation between FFR, IVUS and virtual histology (VH) in intermediate lesions included 350 patients (367 intermediate lesions). Whether to perform an angioplasty procedure or not was the operator’s decision.

ROC analysis identified the 3.07 mm2 global MLA cut-off by IVUS as the best threshold to indentify <0.8 FFR lesions (64% sensitivity, 64% specificity). This global MLA cut-off changes according to the vessel’s reference diameter. For vessels < 3.0 mm in diameter, MLA is <2.4 mm2, vessels between 3.0 and 3.5 mm, MLA = <2.7 mm2 and vessels >3.5 mm, MLA = <3.6 mm2. With these optimal MLA cut-offs by IVUS, taking FFR as gold standard, false positives reached 25.7%. A plaque burden of 68.7 ± 11.2% was the only HV variable which correlated with a <0.8 FFR.

Conclusion 

Anatomical measurement by intravascular ultrasound has a moderate correlation with FFR and depends on the reference diameter.

Comment 

The therapeutic decision for an intermediate lesion should be taken, firstly, following clinical criteria, since both techniques present limitations. IVUS may be a better tool to guide the strategy and monitor the final outcome of an angioplasty procedure, rather than to decide whether to perform it or not.

SOLACI.ORG

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....